lenavapavir $40,000 - SERP Analysis

https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing

https://msfaccess.org/activists-aids2024-demand-break-gileads-lenacapavir-monopoly-gileads-price-100000-higher-target

https://www.nytimes.com/2025/06/18/health/hiv-fda-lenacapavir.html

https://www.ajmc.com/view/cost-will-be-massive-barrier-in-access-to-lenacapavir-after-approval-in-the-us-gordon-crofoot-md-pa

https://www.cnn.com/2024/07/24/health/lenacapavir-preventing-hiv-in-phase-3-study

https://www.idsociety.org/science-speaks-blog/2024/aids-2024-miracle-long-acting-injectable-provides-100-protection-against-hiv-researchers-find/

https://i-base.info/htb/48224

https://www.theguardian.com/society/2025/jun/17/hiv-ending-drug-lenacapavir-manufacture-cost-per-patient-gilead

https://www.dw.com/en/hiv-prophylactic-lenacapavir-very-safe-and-very-expensive/a-70920492

https://genevahealthfiles.substack.com/p/us-fda-approves-new-hiv-prevention-drug-calls-improving-access-to-lenacapavir-get-louder-gilead-mpp

https://sciencemediacentre.es/en/science-magazine-chooses-lenacapavir-prevent-hiv-infection-breakthrough-year

https://www.eatg.org/hiv-news/a-new-drug-could-change-the-hiv-prevention-landscape-but-only-with-a-fair-price-tag/

https://www.contagionlive.com/view/the-evolution-of-lenacapavir

https://www.nbcnews.com/health/health-news/hiv-injection-twice-yearly-offers-protection-rcna163406

https://www.doctorswithoutborders.org/latest/msf-calls-gilead-make-groundbreaking-hiv-prevention-drug-affordable-all

https://itpcglobal.org/2024/07/23/lenacapavir-access/

https://firstwordpharma.com/story/5878383

https://www.healio.com/news/infectious-disease/20241007/lenacapavir-poised-to-transform-hiv-prevention

https://peoplesmedicines.org/resources/media-releases/gilead-hiv-medicine-news-marred-by-little-hope-for-developing-countries/

https://www.everydayhealth.com/hiv-aids/new-injection-offers-protection-against-hiv-in-women/

https://www.npr.org/2025/06/24/nx-s1-5439564/fda-approves-hiv-medication-lenacapavir-but-its-costly

https://i-base.info/htb/47979

https://frontlineaids.org/frontline-aids-urges-gilead-to-make-new-hiv-prevention-drug-lenacapavir-affordable-for-all/

https://www.linkedin.com/posts/business-standard_hiv-medicine-that-costs-42000-could-be-activity-7221821565972201472-Wl4q

https://www.newsnationnow.com/health/highly-effective-hiv-drug-40-yearly/

https://www.gilead.com/company/company-statements/2024/updated-statement-on-global-access-planning-for-lenacapavir-for-hiv-prevention

https://www.jwatch.org/na55689/2023/01/09/lenacapavir-promising-milestone-hiv-1-therapy

https://www.pbs.org/newshour/health/a-twice-yearly-shot-could-help-end-aids-but-only-if-it-can-get-to-everyone-who-needs-it

https://healthjusticeinitiative.org.za/2024/12/02/activist-coalition-demands-accelerated-access-hiv-prevention/

https://www.usatoday.com/story/news/factcheck/2024/12/11/drug-lenacapravir-hiv-cure-fact-check/76875410007/

https://x.com/UNITAID/status/1882018753040519517

https://podcasts.apple.com/us/podcast/lenacapavir-could-new-hiv-drug-help-end-the-pandemic/id1547235591?i=1000663039366

https://www.healthline.com/health-news/sunleca-successful-hiv-prevention

https://www.business-standard.com/health/hiv-medicine-that-costs-42-000-could-be-made-for-just-40-with-profits-124072400443_1.html

https://abc13.com/post/us-food-drug-administration-make-decision-new-injectable-hiv-medication-lenacapavir-mid-june/16706594/

https://www.france24.com/en/live-news/20240722-un-urges-gilead-to-make-history-with-game-changing-hiv-drug

https://www.aidsmap.com/news/jun-2024/no-hiv-infections-seen-groundbreaking-trial-twice-yearly-injectable-prep

https://www.fox5atlanta.com/news/injectable-hiv-preventative-lenacapavir-touted-breakthrough-emory-experts

https://www.straitstimes.com/world/new-vaccine-like-hiv-drug-could-cost-just-40-researchers

https://www.bizjournals.com/sanfrancisco/news/2025/05/15/gilead-lenacapavir-sunlenca-hiv-prep.html

https://healthpolicy-watch.news/huge-advance-for-hiv-prevention-as-injection-trial-proves-100-successful/

https://x.com/Winnie_Byanyima/status/1831024430900015110

https://www.devex.com/news/activists-demand-access-to-groundbreaking-hiv-prevention-tool-108014

https://timesofindia.indiatimes.com/science/new-vaccine-like-hiv-drug-could-cost-just-40-researchers/articleshow/111956500.cms

https://www.nytimes.com/2024/10/02/health/lenacapavir-hiv-shot-prep.html

https://english.almayadeen.net/news/health/-42-000-a-year-hiv-vaccine-trialed-in-africa

https://www.dw.com/en/hiv-breakthrough-drug-priced-out-lenacapavir-video/video-71392475

https://wspartners.bbc.com/clip/p0jczvml

https://www.infectiousdiseaseadvisor.com/news/twice-yearly-injection-reduces-hiv-risk-by-96-but-will-cost-cut-access/

https://www.facebook.com/NewsofBahrain1/posts/%EF%B8%8F-a-new-vaccine-like-hiv-drug-that-currently-costs-over-40000-per-person-a-year-/1204914687629197/

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5293409

https://info3.com/medical-news/178471/text/full/new-vaccinelike-hiv-drug-lenacapavir-could-cost-just-40

https://twitter.com/STOPAIDS/status/1828472108155818275

https://www.reddit.com/r/science/comments/1ebssy8/a_new_antihiv_injection_giving_total_protection/

https://www.commondreams.org/news/prep-hiv

https://healthgap.org/press/gileads-access-strategy-for-lenacapavir-will-unnecessarily-prolong-the-hiv-pandemic-activists-call-for-affordable-access-for-all-low-and-middle-income-countries/

https://www.weforum.org/stories/2025/01/new-hiv-medicines-could-end-aids/

https://www.ebar.com/story/155332

https://www.webull.com/news/13007403174454272

https://msfsouthasia.org/activists-at-aids2024-demand-break-gileads-lenacapavir-monopoly/

https://www.newagebd.net/post/mis/240590/new-vaccine-like-hiv-drug-could-cost-just-40-researchers

https://healthgap.org/press/activists-at-aids2024-demand-break-gileads-lenacapavir-monopoly-gileads-price-10000-higher-than-target-generic-price-for-100-effective-prevention-shot/

https://bhiva.org/wp-content/uploads/2025/05/Andrew-Hill.pdf

https://www.msf.org.za/news-and-resources/press-release/msf-calls-gilead-make-groundbreaking-hiv-prevention-drug

https://medicineslawandpolicy.org/2025/06/fda-approval-of-injectable-lenacapavir-for-pre-exposure-prophylaxis-prep-opens-the-road-to-ending-hiv/

https://www.huntingtonhealth.org/in-the-news/new-study-shows-promising-drug-for-hiv-prevention/

https://www.deccanchronicle.com/world/new-vaccine-like-hiv-drug-could-cost-just-40-researchers-1811830

https://www.cato.org/blog/new-hiv-prevention-drug-approved-now-lets-remove-final-barrier

https://www.iflscience.com/hiv-drug-that-is-closest-thing-we-have-to-a-vaccine-could-be-made-1000-times-cheaper-75217

https://makemedicinesaffordable.org/the-case-for-compulsory-licensing-of-lenacapavir/

https://www.medscape.com/viewarticle/986049

https://www.clinicaladvisor.com/news/twice-yearly-injection-cuts-hiv-risk-by-96-but-will-cost-cut-access/

https://www.pharmexec.com/view/new-beginnings-sunlenca

https://www.kelinkenya.org/25th-international-aids-conference-kelin-joins-global-call-against-gilead/

https://infojustice.org/archives/45834

https://www.linkedin.com/posts/phys-org_new-vaccine-like-hiv-drug-could-cost-just-activity-7221443945992437760-Whwe

https://knockout.chat/thread/63577

https://www.instagram.com/p/DDBoTqsTDOR/

https://press.asimov.com/articles/hiv-medicine

https://www.nature.com/articles/s41587-024-02369-y

https://m.facebook.com/story.php/?story_fbid=1160138106114266&id=100063542635568

https://healthmanagement.org/c/hospital/News/hiv-prevention-gileads-lenacapavir-the-ongoing-search-for-a-vaccine

https://www.eatg.org/hiv-news/aids-activists-delight-in-hiv-prevention-trial-results-and-press-gilead-to-lower-price-of-miracle-drug/

https://en.ittefaq.com.bd/9839/lenacapavir-safe-but-costly-hiv-prophylactic

https://www.drugs.com/news/twice-yearly-cuts-hiv-risk-96-but-cost-cut-access-121290.html

https://www.amfar.org/news/new-research-frontiers-and-funding-fears/

https://ahflatamycaribe.org/en/over-250-organizations-in-latin-america-demand-equitable-access-to-lenacapavir/

https://www.stdrapidtestkits.com/blog/post/twice-yearly-prep-is-here-how-lenacapavir-could-revolutionize-hiv-prevention-in-2025?srsltid=AfmBOoo8mKBlJxSC3mVaqJTzyJ04uEhTzSudFEDBSzBpJ4SvIY-7gye1

http://www.sfaf.org/collections/beta/digging-into-the-science-and-promise-of-long-acting-injectable-prep/

https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/antiretroviral-therapy-cost-considerations

https://itpcglobal.org/2024/11/14/global-south-leaders-condemn-gileads-restrictive-license-on-hiv-prevention-breakthrough/

https://www.reddit.com/r/hivaids/comments/1foa51m/act_up_london_protest_outside_pharma_co_gilead/

https://makemedicinesaffordable.org/hiv-community-based-organizations-are-fighting-patent-monopolies-on-lenacapavir/

https://www.koat.com/article/a-twice-yearly-shot-could-help-end-aids/63061380

https://vativorx.com/pharmacy-bulletin-12-22-2022/

https://www.commondreams.org/tag/lenacapavir

https://slguardian.org/breakthrough-hiv-prevention-annual-lenacapavir-injections-show-promise/

https://www.instagram.com/its_onsite/p/DDGLAMoxwXf/?locale=hi_IN&hl=ar

https://mainichi.jp/english/articles/20241201/p2g/00m/0sc/053000c